🎉 M&A multiples are live!
Check it out!

Treatment | AI Valuation Multiples

Discover revenue and EBITDA valuation multiples for Treatment | AI and other public comps.

See Treatment | AI Valuation Multiples

Treatment | AI Overview

About Treatment | AI

Treatment com AI Inc operates in the business of providing personalized health care information that is relevant and trustworthy empowering patients to make responsible, informed decisions about their health while improving communications, reducing costs and in-clinic wait times for medical practitioners.


Founded

2018

HQ

Canada
Employees

n/a

Website

treatment.com

Financials

LTM Revenue n/a

LTM EBITDA n/a

EV

$20.3M

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Treatment | AI Financials

Treatment | AI has a last 12-month revenue of n/a and a last 12-month EBITDA of n/a.

In the most recent fiscal year, Treatment | AI achieved revenue of n/a and an EBITDA of -$2.5M.

Treatment | AI expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See Treatment | AI valuation multiples based on analyst estimates

Treatment | AI P&L

FY 2022 FY 2023 FY 2024 LTM NTM
Revenue n/a n/a n/a n/a XXX
Gross Profit n/a n/a n/a XXX XXX
Gross Margin NaN% NaN% NaN% XXX XXX
EBITDA -$9.6M -$2.6M -$2.5M n/a XXX
EBITDA Margin -Infinity% -Infinity% -Infinity% NaN% XXX
Net Profit -$9.6M -$2.6M -$2.6M XXX XXX
Net Margin -Infinity% -Infinity% -Infinity% XXX XXX
Net Debt n/a $0.4M n/a XXX XXX

Financial data powered by Morningstar, Inc.

Treatment | AI Stock Performance

As of February 14, 2025, Treatment | AI's stock price is CAD 1 (or $0).

Treatment | AI has current market cap of CAD 29.4M (or $20.4M), and EV of CAD 29.3M (or $20.3M).

See Treatment | AI trading valuation data

Treatment | AI Stock Data

EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$20.3M $20.4M XXX XXX XXX XXX n/a

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Sign Up

Treatment | AI Valuation Multiples

As of February 14, 2025, Treatment | AI has market cap of $20.4M and EV of $20.3M.

Treatment | AI's trades at n/a LTM EV/Revenue multiple, and n/a LTM EBITDA.

Analysts estimate Treatment | AI's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See valuation multiples for Treatment | AI and 10K+ public comps

Treatment | AI Financial Valuation Multiples

FY 2024 FY 2025E FY 2026E FY 2027E
EV $20.3M XXX XXX XXX
EV/Revenue n/a XXX XXX XXX
EV/EBITDA n/a XXX XXX XXX
P/E n/a XXX XXX XXX
P/E/Growth n/a XXX XXX XXX
EV/FCF n/a XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Treatment | AI Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Sign Up

Treatment | AI Valuation Multiples

Treatment | AI's NTM/LTM revenue growth is n/a

Treatment | AI's revenue per employee for the last fiscal year averaged n/a, while opex per employee averaged n/a for the same period.

Over next 12 months, Treatment | AI's ratio of sales and marketing spend to revenue is estimated to be  XXX , while its R&D spend to revenue to be  XXX .

Analysts estimate Treatment | AI's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See operational valuation multiples for Treatment | AI and other 10K+ public comps

Treatment | AI Operational Valuation Multiples

FY 2024 NTM FY 2025E FY 2026E FY 2027E
Revenue Growth n/a XXX XXX XXX XXX
EBITDA Margin n/a XXX XXX XXX XXX
EBITDA Growth -3% XXX XXX XXX XXX
Rule of 40 (SaaS-only) n/a XXX XXX XXX XXX
Revenue per Employee n/a XXX XXX XXX XXX
Opex per Employee n/a XXX XXX XXX XXX
S&M Expenses to Revenue n/a XXX XXX XXX XXX
G&A Expenses to Revenue n/a XXX XXX XXX XXX
R&D Expenses to Revenue n/a XXX XXX XXX XXX
Opex to Revenue n/a XXX XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Medical Devices
Consumer SaaS
Streaming Platforms
AdTech Software
Climate Tech
GRC Software
Developer Tools

Treatment | AI Public Comps

See valuation multiples for Treatment | AI public comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Benevolent AI XXX XXX XXX XXX XXX XXX
Alcidion Group XXX XXX XXX XXX XXX XXX
CurveBeam AI XXX XXX XXX XXX XXX XXX
Doctor Care Anywhere XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

Treatment | AI M&A and Investment Activity

Treatment | AI acquired  XXX companies to date.

Last acquisition by Treatment | AI was  XXXXXXXX, XXXXX XXXXX XXXXXX . Treatment | AI acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by Treatment | AI

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.

Sign Up

About Treatment | AI

When was Treatment | AI founded? Treatment | AI was founded in 2018.
Where is Treatment | AI headquartered? Treatment | AI is headquartered in Canada.
Is Treatment | AI publicy listed? Yes, Treatment | AI is a public company listed on CNQ.
What is the stock symbol of Treatment | AI? Treatment | AI trades under TRUE ticker.
When did Treatment | AI go public? Treatment | AI went public in 2021.
Who are competitors of Treatment | AI? Similar companies to Treatment | AI include e.g. Benevolent AI, Alcidion Group, CurveBeam AI, Doctor Care Anywhere.
What is the current market cap of Treatment | AI? Treatment | AI's current market cap is $20.4M
Is Treatment | AI profitable? Yes, Treatment | AI is EBITDA-positive (as of the last 12 months).

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.